Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasisMarch 11, 2022SpondyloarthropathiesRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitis
Updated perioperative guidance says when to hold antirheumaticsMarch 4, 2022Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitisOrthopedics
One-third of psoriatic arthritis patients could have metabolic syndrome, data analysis findsMarch 4, 2022Psoriatic ArthritisMixed Topics
Patients are interrupting DMARD use well into the COVID-19 pandemicFebruary 17, 2022COVID-19 UpdatesRheumatoid ArthritisPsoriatic ArthritisLupus & Connective Tissue Diseases
Dietary recommendations for inflammatory rheumatic diseasesFebruary 10, 2022Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
More frequent secukinumab dosing found to benefit overweight psoriasis patientsJanuary 26, 2022Psoriatic ArthritisMixed Topics
Proactive infliximab monitoring found best for sustaining control of inflammatory diseasesJanuary 10, 2022Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathies
Case series show no consensus on treatment for palmoplantar pustulosis, generalized pustular psoriasisJanuary 4, 2022Psoriatic Arthritis
Spesolimab speeds lesion clearance in generalized pustular psoriasisDecember 27, 2021Psoriatic Arthritis
